Your browser doesn't support javascript.
loading
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.
Kim, Sungjune; Wuthrick, Evan; Blakaj, Dukagjin; Eroglu, Zeynep; Verschraegen, Claire; Thapa, Ram; Mills, Matthew; Dibs, Khaled; Liveringhouse, Casey; Russell, Jeffery; Caudell, Jimmy J; Tarhini, Ahmad; Markowitz, Joseph; Kendra, Kari; Wu, Richard; Chen, Dung-Tsa; Berglund, Anders; Michael, Lauren; Aoki, Mia; Wang, Min-Hsuan; Hamaidi, Imene; Cheng, Pingyan; de la Iglesia, Janis; Slebos, Robbert J; Chung, Christine H; Knepper, Todd C; Moran-Segura, Carlos M; Nguyen, Jonathan V; Perez, Bradford A; Rose, Trevor; Harrison, Louis; Messina, Jane L; Sondak, Vernon K; Tsai, Kenneth Y; Khushalani, Nikhil I; Brohl, Andrew S.
Afiliación
  • Kim S; Department of Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA; Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Electronic address: sungjune.kim@moffitt.org.
  • Wuthrick E; Department of Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Blakaj D; Department of Radiation Oncology, Ohio State University James Cancer Hospital Solove Research Institute, Columbus, OH, USA.
  • Eroglu Z; Department of Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Verschraegen C; Department of Medical Oncology, Ohio State University James Cancer Hospital Solove Research Institute, Columbus, OH, USA.
  • Thapa R; Department of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Mills M; Department of Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Dibs K; Department of Radiation Oncology, Ohio State University James Cancer Hospital Solove Research Institute, Columbus, OH, USA.
  • Liveringhouse C; Department of Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Russell J; Department of Head and Neck and Cutaneous Oncology, University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Caudell JJ; Department of Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Tarhini A; Department of Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Markowitz J; Department of Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Kendra K; Department of Medical Oncology, Ohio State University James Cancer Hospital Solove Research Institute, Columbus, OH, USA.
  • Wu R; Department of Medical Oncology, Ohio State University James Cancer Hospital Solove Research Institute, Columbus, OH, USA.
  • Chen DT; Department of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Berglund A; Department of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Michael L; Department of Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Aoki M; Department of Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Wang MH; Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Hamaidi I; Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Cheng P; Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • de la Iglesia J; Department of Pathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Slebos RJ; Department of Head and Neck Endocrine Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Chung CH; Department of Head and Neck Endocrine Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Knepper TC; Department of Precision Medicine, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Moran-Segura CM; Department of Pathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Nguyen JV; Department of Pathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Perez BA; Department of Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Rose T; Department of Radiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Harrison L; Department of Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Messina JL; Department of Pathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Sondak VK; Department of Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Tsai KY; Department of Pathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Khushalani NI; Department of Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Brohl AS; Department of Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Lancet ; 400(10357): 1008-1019, 2022 09 24.
Article en En | MEDLINE | ID: mdl-36108657

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células de Merkel / Radiocirugia Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células de Merkel / Radiocirugia Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article